<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Anesthesiol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Anesthesiol</journal-id><journal-title-group><journal-title>BMC Anesthesiology</journal-title></journal-title-group><issn pub-type="epub">1471-2253</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24860256</article-id><article-id pub-id-type="pmc">4032635</article-id><article-id pub-id-type="publisher-id">1471-2253-14-39</article-id><article-id pub-id-type="doi">10.1186/1471-2253-14-39</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Intubating conditions and side effects of propofol, remifentanil and sevoflurane compared with propofol, remifentanil and rocuronium: a randomised, prospective, clinical trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Mencke</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>thomas.mencke@googlemail.com</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Jacobs</surname><given-names>Refa Maria</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>r-m.jacobs@web.de</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Machmueller</surname><given-names>Susann</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>susann.machmueller@uni-rostock.de</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Sauer</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>martinsauer.sauer@googlemail.com</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Heidecke</surname><given-names>Christine</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>christine.heidecke@gmx.de</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Kallert</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>anja.kallert@med.uni-rostock.de</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Pau</surname><given-names>Hans Wilhelm</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>hans-wilhelm.pau@med.uni-rostock.de</email></contrib><contrib contrib-type="author" id="A8"><name><surname>Noeldge-Schomburg</surname><given-names>Gabriele</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>gabriele.noeldge-schomburg@uni-rostock.de</email></contrib><contrib contrib-type="author" id="A9"><name><surname>Ovari</surname><given-names>Attila</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>atiova@gmail.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Anaesthesia and Intensive Care Medicine, University of Rostock, Schillingallee 35, Rostock 18057, Germany</aff><aff id="I2"><label>2</label>Department of Otorhinolaryngology, University of Rostock, Rostock, Germany</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>22</day><month>5</month><year>2014</year></pub-date><volume>14</volume><fpage>39</fpage><lpage>39</lpage><history><date date-type="received"><day>16</day><month>1</month><year>2014</year></date><date date-type="accepted"><day>30</day><month>4</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Mencke et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Mencke et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2253/14/39"/><abstract><sec><title>Background</title><p>Tracheal intubation without muscle relaxants is usually performed with remifentanil and propofol or sevoflurane. Remifentanil 1.0 to 4.0&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup> and propofol 2.0-3.0&#x000a0;mg&#x000b7;kg<sup>-1</sup> or sevoflurane up to 8.0 Vol% provide acceptable, i.e. excellent or good intubating conditions. We hypothesized that sevoflurane 1.0 MAC would provide acceptable intubating conditions when combined with propofol and remifentanil.</p></sec><sec><title>Methods</title><p>Eighty-three patients to be intubated were randomised to two groups. The SEVO group received propofol 1.5&#x000a0;mg&#x000a0;kg<sup>-1</sup>, remifentanil 0.30&#x000a0;&#x003bc;g&#x000a0;kg&#x000a0;min<sup>-1</sup> and sevoflurane 1.0 MAC; the MR group received the same doses of propofol and remifentanil plus rocuronium 0.45&#x000a0;mg&#x000a0;kg<sup>-1</sup>. We evaluated intubation and extubation conditions, mean arterial pressure (MAP), heart rate (HR) and bispectral index (BIS). The vocal cords were examined for injury by videolaryngoscopy before and 24&#x000a0;hours after surgery.</p></sec><sec><title>Results</title><p>Acceptable intubating conditions were seen more frequently with rocuronium than with sevoflurane: 97% versus 82%; p&#x02009;=&#x02009;0.03; the subscore for vocal cords was comparable: 100% versus 98%. MAP before intubation decreased significantly compared with the MAP at baseline to the same extent in both groups; ephedrine IV was given in 15 (SEVO) versus 16 (MR) patients; p&#x02009;=&#x02009;0.93. BIS at tracheal intubation was 27 (13-65) in the SEVO group, 29 (14-62) in the MR group; p&#x02009;=&#x02009;0.07. Vocal cord injuries (oedema, haematoma) were similar: 4 patients in each group.</p></sec><sec><title>Conclusions</title><p>Overall intubating conditions were better when rocuronium was used; the subscore for vocal cords was comparable. The incidence of side effects was the same in the two groups.</p></sec><sec><title>Trial registration</title><p>ClinicalTrials.Gov: <ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov/ct2/show/NCT01591031">NCT 01591031</ext-link>.</p></sec></abstract><kwd-group><kwd>Sevoflurane</kwd><kwd>Propofol</kwd><kwd>Remifentanil</kwd><kwd>Neuromuscular block</kwd><kwd>Intubating conditions</kwd><kwd>Laryngeal injury</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Tracheal intubation without neuromuscular blocking agents (NMBAs) is performed mainly with remifentanil and propofol [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]; alfentanil, fentanyl and sufentanil are alternative opioids [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. Alternative hypnotic agents are etomidate, thiopental and sevoflurane [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. Because poor intubating conditions are associated with vocal cord injury [<xref ref-type="bibr" rid="B3">3</xref>] it is important to achieve good or excellent, i.e., acceptable, intubating conditions. Remifentanil, 1.0 to 4.0&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup> combined with propofol, provides acceptable intubating conditions [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>], but these doses may cause arterial hypotension and severe bradycardia [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. The remifentanil infusion rate can be reduced when a volatile anaesthetic such as isoflurane is added rather than propofol [<xref ref-type="bibr" rid="B9">9</xref>]. Sevoflurane 8 Vol% (i.e., 4.0 minimal alveolar concentration; MAC) combined with remifentanil 2.0&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup> provided acceptable intubating conditions in 97% of patients, but mean arterial pressure (MAP) decreased by about 25% [<xref ref-type="bibr" rid="B7">7</xref>]. We hypothesized that sevoflurane 1.0 MAC would provide clinically acceptable intubating conditions, when combined with a standard anaesthesia induction with propofol and a continuous infusion of remifentanil.</p></sec><sec sec-type="methods"><title>Methods</title><p>The SEVO (sevoflurane) group received propofol, remifentanil and sevoflurane 1.0 MAC; the MR (muscle relaxant) group received propofol, remifentanil and rocuronium 0.45&#x000a0;mg&#x000b7;kg<sup>-1</sup>. The primary outcome measure was the intubation score [<xref ref-type="bibr" rid="B10">10</xref>]. Secondary outcome measures were MAP, heart rate (HR) and bispectral index (BIS); in addition, we assessed the incidence and severity of vocal cord injuries at 24&#x000a0;hours after surgery by videolaryngoscopy, the incidence and severity of hoarseness and sore throat up to 72&#x000a0;hours after surgery.</p><sec><title>Ethics approval and registration</title><p>This prospective, randomised, clinical study was conducted between April 2012 and January 2013 at the University Hospital of Rostock, Germany. Ethical approval was provided by the Institutional Review Committee (Ethikkommission der Universitaet Rostock, Rostock, Germany; registration number: A 2011 124) on 3 November 2011. The study was registered at ClinicalTrials.Gov with the number NCT 01591031.</p></sec><sec><title>Inclusion and exclusion criteria</title><p>After obtaining written informed consent, we studied 88 patients, American Society of Anesthesiologist (ASA) grade I-III aged 18-80 years, who required orotracheal intubation for ear surgery. Exclusion criteria were a known or suspected difficult airway, such as mouth opening&#x02009;&#x0003c; 3.5&#x000a0;cm or Mallampati score 4 or Cormack grade 3 and 4; obesity; disease of the larynx or vocal cords; hoarseness before surgery; and a preexisting severe vocal cord pathology discovered at videolaryngoscopy by an ear-nose-throat (ENT) physician before surgery.</p></sec><sec><title>Randomisation and monitoring</title><p>A randomisation program was used [<xref ref-type="bibr" rid="B11">11</xref>]. Patients in group MR were monitored with acceleromyography to achieve maximum neuromuscular block at the time of tracheal intubation in the MR group, i.e, when the TOF counts disappeared. Neuromuscular monitoring was performed with the TOF Watch SX&#x000ae; device (Organon Teknika, Eppelheim, Germany). Neuromonitoring was performed in all with the BIS Vista&#x000ae; brain monitoring system (Aspect Medical Systems, Norwood, MA, USA). It was used to measure the depth of anaesthesia at time of tracheal intubation. Blood pressure was measured non-invasively every 2&#x000a0;minutes during induction of anaesthesia and afterwards every 5&#x000a0;minutes.</p></sec><sec><title>Induction and maintenance of anaesthesia</title><p>All patients received midazolam 7.5&#x000a0;mg orally before arrival in the anaesthetic room, where they were given dexamethasone 4.0&#x000a0;mg IV and ondansetrone 4.0&#x000a0;mg IV. Induction of anaesthesia was standardised: all patients received remifentanil 0.30&#x000a0;&#x003bc;g&#x000b7;kg&#x000b7;min<sup>-1</sup> for three minutes, after which propofol 1.5&#x000a0;mg&#x000b7;kg<sup>-1</sup> was given (if necessary 30&#x000a0;mg was supplemented). After the propofol, the SEVO group received sevoflurane at an inspired concentration of 3.0-3.5 Vol% (fresh gas flow 8&#x000a0;l&#x000b7;min<sup>-1</sup>). After 2-3 minutes, when the endtidal sevofluane concentration reached 1.0 MAC (stable for 20&#x000a0;s), intubation was performed. MAC was calculated from the age of the patient with the software from the Primus&#x000ae; anaesthetic machine (Dr&#x000e4;ger Medical Germany, L&#x000fc;beck, Germany). The sevoflurane was discontinued after intubation. In the MR group, after propofol, rocuronium 0.45&#x000a0;mg&#x000b7;kg<sup>-1</sup> was given after calibration of the TOF watch SX. If maximum block did not occur, a further 0.15&#x000a0;mg&#x000b7;kg<sup>-1</sup> rocuronium was added. The trachea was intubated when maximum block was achieved, by the same anaesthesiologist each time.</p><p>Maintenance of anaesthesia was by propofol 4.0 &#x02013; 6.0&#x000a0;mg&#x000b7;kg&#x000b7;h<sup>-1</sup> and remifentanil 0.20-0.30&#x000a0;&#x003bc;g&#x000b7;kg&#x000b7;min<sup>-1</sup> in both groups. Ephedrine 5-10&#x000a0;mg IV was given if systolic pressure decreased by 20% and/or below 100&#x000a0;mmHg and atropine IV if the HR decreased below 45&#x000a0;min<sup>-1</sup>. The patients were extubated when they opened their eyes and/or began to cough. They were then moved to the postanaesthesia care unit (PACU).</p></sec><sec><title>Intubating conditions, intubating variables and extubating conditions</title><p>Intubating conditions were assessed according to the GCRP guidelines (see Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>) [<xref ref-type="bibr" rid="B10">10</xref>]. Extubating conditions assessed during removal of the tracheal tube were defined as follows: excellent&#x02009;=&#x02009;no coughing and no movement of the limbs, good&#x02009;=&#x02009;slight coughing or slight movement of the limbs or both; poor&#x02009;=&#x02009;sustained coughing and/or vigorous movement of the limbs during extubation. Intubating variables were assessed: application of back upward right pressure (BURP), Cormack and Lehane grade, time for intubation and number of intubation attempts (see Appendix). We used RAE tubes (Mallinckrodt&#x000ae;, Covidien, Dublin, Irland) standardized to 8.0&#x000a0;mm for men and 7.0&#x000a0;mm for women. Cuff pressure was measured and adjusted continuously below 25&#x000a0;cm&#x000a0;H<sub>2</sub>0 by a cuff pressure monitor. No gastric tubes or intubation stylets were used.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Scoring conditions for tracheal intubation</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left" valign="bottom">&#x000a0;<hr/></th><th colspan="3" align="left" valign="bottom"><bold>Intubating scores</bold><hr/></th></tr><tr><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom"><bold>Clinically acceptable</bold><hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom"><bold>Clinically not acceptable</bold><hr/></th></tr><tr><th align="left"><bold>Variable</bold></th><th align="left"><bold>Excellent</bold></th><th align="left"><bold>Good</bold></th><th align="left"><bold>Poor</bold></th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>Laryngoscopy</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Jaw relaxation<hr/></td><td align="left" valign="bottom">Relaxed<hr/></td><td align="left" valign="bottom">Not fully<hr/></td><td align="left" valign="bottom">Poor<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Resistance to laryngoscope<hr/></td><td align="left" valign="bottom">None<hr/></td><td align="left" valign="bottom">Slight<hr/></td><td align="left" valign="bottom">Active<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Vocal cords</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Position<hr/></td><td align="left" valign="bottom">Abducted<hr/></td><td align="left" valign="bottom">Intermediate<hr/></td><td align="left" valign="bottom">Closed<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Movement<hr/></td><td align="left" valign="bottom">None<hr/></td><td align="left" valign="bottom">Moving<hr/></td><td align="left" valign="bottom">Closing<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Reaction to tube insertion or cuff inflation</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Movement of limbs<hr/></td><td align="left" valign="bottom">None<hr/></td><td align="left" valign="bottom">Slight<hr/></td><td align="left" valign="bottom">Vigorous<hr/></td></tr><tr><td align="left">&#x02003;&#x02002;Coughing</td><td align="left">None</td><td align="left">Slight</td><td align="left">Sustained</td></tr></tbody></table><table-wrap-foot><p>Intubating conditions: excellent&#x02009;=&#x02009;all qualities are excellent; good&#x02009;=&#x02009;all qualities are excellent or good; poor&#x02009;=&#x02009;any quality is poor. Excellent and good intubating conditions are summarised as clinically acceptable conditions [<xref ref-type="bibr" rid="B10">10</xref>].</p></table-wrap-foot></table-wrap></sec><sec><title>Hoarseness and sore throat</title><p>Hoarseness and sore throat were assessed in the PACU and daily up to 72&#x000a0;hours by a physician blinded to the patient&#x02019;s group assignment. The incidence and severity of hoarseness (defined as change in the acoustic quality) and sore throat (defined as a continuous throat pain) were assessed according to 4 point scales (see Appendix) [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>].</p></sec><sec><title>Vocal cord injuries</title><p>All patients underwent laryngoscopy before surgery by an ENT physician who was blinded to the patient&#x02019;s group. Slight changes, such as erythema, and vocal cord injuries, such as oedema, haematoma and granuloma by videolaryngoscopy (see Appendix) were noted. The recordings before and after surgery were compared; any changes were assessed as to the possibility that they could be caused by intubation.</p></sec><sec><title>Statistical analysis</title><p>We used the SigmaStat&#x000ae; for Windows Version 3.5, (Systat Sotware Inc., San Jose, California, USA). Demographic data were analysed using Mann-Whitney <italic>U</italic>-test or <italic>t</italic>-test. Comparisons between the study groups were performed using the &#x003c7;<sup>2</sup>test, Fisher&#x02019;s exact test or Kruskal-Wallis ANOVA test. Results were considered statistically significant when p&#x02009;&#x0003c;&#x02009;0.05.</p><p>A sample size calculation assumed an incidence of acceptable intubating conditions of 100% in the rocuronium group and 75% in the sevoflurane group. Therefore we needed 66 patients (33 patients in each group; &#x003b1;&#x02009;=&#x02009;0.05, 1-&#x003b2;&#x02009;=&#x02009;80%).</p></sec></sec><sec sec-type="results"><title>Results</title><p>We randomised 83 patients; 43 to the SEVO group and 40 to the MR group (see Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref>). Patient characteristics were comparable (Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>). BMI was less, but not significantly in the SEVO group (p&#x02009;=&#x02009;0.06). The duration of anaesthesia was significantly greater in the MR group (p&#x02009;=&#x02009;0.01). BIS values and use of ephedrine were similar (Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>). Table&#x000a0;<xref ref-type="table" rid="T3">3</xref> shows the haemodynamic response to tracheal intubation.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Flow chart of patient distribution.</p></caption><graphic xlink:href="1471-2253-14-39-1"/></fig><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Patient characteristics, duration of anaesthesia, BIS and ephedrine administration</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th rowspan="2" align="left" valign="top">&#x000a0;</th><th align="left" valign="bottom"><bold>SEVO group</bold><hr/></th><th align="left" valign="bottom"><bold>MR group</bold><hr/></th><th rowspan="2" align="left" valign="top"><bold>P</bold></th></tr><tr><th align="left"><bold>(n&#x02009;=&#x02009;39)</bold></th><th align="left"><bold>(n&#x02009;=&#x02009;40)</bold></th></tr></thead><tbody><tr><td align="left" valign="bottom">Age (yr)<hr/></td><td align="left" valign="bottom">48&#x02009;&#x000b1;&#x02009;17<hr/></td><td align="left" valign="bottom">50&#x02009;&#x000b1;&#x02009;16<hr/></td><td align="left" valign="bottom">0.67<hr/></td></tr><tr><td align="left" valign="bottom">Weight (kg)<hr/></td><td align="left" valign="bottom">79.6&#x02009;&#x000b1;&#x02009;15<hr/></td><td align="left" valign="bottom">83.8&#x02009;&#x000b1;&#x02009;16<hr/></td><td align="left" valign="bottom">0.23<hr/></td></tr><tr><td align="left" valign="bottom">Height (cm)<hr/></td><td align="left" valign="bottom">173&#x02009;&#x000b1;&#x02009;11<hr/></td><td align="left" valign="bottom">172&#x02009;&#x000b1;&#x02009;9<hr/></td><td align="left" valign="bottom">0.70<hr/></td></tr><tr><td align="left" valign="bottom">Body mass index (kg&#x000b7;m<sup>-2</sup>)<hr/></td><td align="left" valign="bottom">26.5&#x02009;&#x000b1;&#x02009;3.7<hr/></td><td align="left" valign="bottom">28.2&#x02009;&#x000b1;&#x02009;4.3<hr/></td><td align="left" valign="bottom">0.06<hr/></td></tr><tr><td align="left" valign="bottom">Gender ratio (female/male)<hr/></td><td align="left" valign="bottom">16/23<hr/></td><td align="left" valign="bottom">16/24<hr/></td><td align="left" valign="bottom">0.89<hr/></td></tr><tr><td align="left" valign="bottom">ASA I/II/III<hr/></td><td align="left" valign="bottom">5/30/4<hr/></td><td align="left" valign="bottom">3/33/4<hr/></td><td align="left" valign="bottom">0.73<hr/></td></tr><tr><td align="left" valign="bottom">Duration of anaesthesia (min)<hr/></td><td align="left" valign="bottom">81 (38-193)<hr/></td><td align="left" valign="bottom">121 (48-214)<hr/></td><td align="left" valign="bottom">0.01<hr/></td></tr><tr><td align="left" valign="bottom">BIS at tracheal intubation<hr/></td><td align="left" valign="bottom">27 (13-65)<hr/></td><td align="left" valign="bottom">29 (14-62)<hr/></td><td align="left" valign="bottom">0.07<hr/></td></tr><tr><td align="left" valign="bottom">BIS at tracheal extubation<hr/></td><td align="left" valign="bottom">72 (43-91)<hr/></td><td align="left" valign="bottom">71 (42-88)<hr/></td><td align="left" valign="bottom">0.89<hr/></td></tr><tr><td align="left">Administration of ephedrine (n)</td><td align="left">15 (38)</td><td align="left">16 (40)</td><td align="left">0.93</td></tr></tbody></table><table-wrap-foot><p>Values are mean&#x02009;&#x000b1;&#x02009;SD, or numbers (%) or median (range). BIS&#x02009;=&#x02009;bispectral index.</p><p>SEVO group&#x02009;=&#x02009;Induction of anaesthesia with sevoflurane.</p><p>MR group&#x02009;=&#x02009;Induction of anaesthesia with rocuronium.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Induction of anaesthesia and haemodynamic response to tracheal intubation</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th rowspan="2" align="left" valign="top">&#x000a0;</th><th align="left" valign="bottom"><bold>SEVO group</bold><hr/></th><th align="left" valign="bottom"><bold>MR group</bold><hr/></th><th rowspan="2" align="left" valign="top"><bold>P</bold></th></tr><tr><th align="left"><bold>(n&#x02009;=&#x02009;39)</bold></th><th align="left"><bold>(n&#x02009;=&#x02009;40)</bold></th></tr></thead><tbody><tr><td align="left" valign="bottom">Mean arterial pressure (mmHg)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Preinduction<hr/></td><td align="left" valign="bottom">92&#x02009;&#x000b1;&#x02009;11<hr/></td><td align="left" valign="bottom">95&#x02009;&#x000b1;&#x02009;11<hr/></td><td align="left" valign="bottom">0.18<hr/></td></tr><tr><td align="left" valign="bottom">Postinduction<hr/></td><td align="left" valign="bottom">65&#x02009;&#x000b1;&#x02009;9*<hr/></td><td align="left" valign="bottom">65&#x02009;&#x000b1;&#x02009;8*<hr/></td><td align="left" valign="bottom">0.98<hr/></td></tr><tr><td align="left" valign="bottom">Postintubation<hr/></td><td align="left" valign="bottom">67&#x02009;&#x000b1;&#x02009;6*<hr/></td><td align="left" valign="bottom">68&#x02009;&#x000b1;&#x02009;9*<hr/></td><td align="left" valign="bottom">0.34<hr/></td></tr><tr><td align="left" valign="bottom">Heart rate (beats/min)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Preinduction<hr/></td><td align="left" valign="bottom">71&#x02009;&#x000b1;&#x02009;12<hr/></td><td align="left" valign="bottom">77&#x02009;&#x000b1;&#x02009;14<hr/></td><td align="left" valign="bottom">0.05<hr/></td></tr><tr><td align="left" valign="bottom">Postinduction<hr/></td><td align="left" valign="bottom">63&#x02009;&#x000b1;&#x02009;10*<hr/></td><td align="left" valign="bottom">65&#x02009;&#x000b1;&#x02009;11*<hr/></td><td align="left" valign="bottom">0.51<hr/></td></tr><tr><td align="left">Postintubation</td><td align="left">60&#x02009;&#x000b1;&#x02009;10*</td><td align="left">65&#x02009;&#x000b1;&#x02009;10*</td><td align="left">0.03</td></tr></tbody></table><table-wrap-foot><p>Values are mean&#x02009;&#x000b1;&#x02009;SD. *p&#x02009;&#x0003c;&#x02009;0.05 versus preinduction values.</p><p>Preinduction&#x02009;=&#x02009;before induction of anaesthesia; Postinduction&#x02009;=&#x02009;3&#x000a0;min after induction of anaesthesia but before tracheal intubation; Postintubation&#x02009;=&#x02009;2&#x000a0;min after tracheal intubation.</p><p>SEVO group&#x02009;=&#x02009;Induction of anaesthesia with sevoflurane.</p><p>MR group&#x02009;=&#x02009;Induction of anaesthesia with rocuronium.</p></table-wrap-foot></table-wrap><sec><title>Intubating conditions, intubating variables and extubating conditions</title><p>Tracheal intubation was possible in all patients, but two patients from the SEVO group could only be intubated after administration of rocuronium (see Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref>). The vocal cords were closed and did not open after propofol 30&#x000a0;mg IV; to avoid vocal cord injuries, rocuronium 0.45&#x000a0;mg&#x000b7;kg<sup>-1</sup> was given. Overall intubating conditions were not significantly better in group MR (p&#x02009;=&#x02009;0.06). However, acceptable intubating conditions (excellent and good) were significantly more common (p&#x02009;=&#x02009;0.03; Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>). The subscores for the vocal cords were not significantly different, but the subscore reaction to tube insertion or cuff inflation was significantly better in group MR (p&#x02009;=&#x02009;0.02; Figures&#x000a0;<xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref> and <xref ref-type="fig" rid="F5">5</xref>). Intubating variables and extubating conditions are shown in Table&#x000a0;<xref ref-type="table" rid="T4">4</xref>.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Patients (%) with excellent (black bars), good (grey bars) and poor intubation conditions (white bars).</bold> *p&#x02009;=&#x02009;0.06 MR group versus SEVO group overall; p&#x02009;=&#x02009;0.029 clinically acceptable (excellent and good) conditions. SEVO group&#x02009;=&#x02009;Induction of anaesthesia with sevoflurane. MR group&#x02009;=&#x02009;Induction of anaesthesia with rocuronium.</p></caption><graphic xlink:href="1471-2253-14-39-2"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Patients (%) with excellent (black bars), good (grey bars) and poor intubation conditions (white bars) for subscore laryngoscopy.</bold> *p&#x02009;=&#x02009;0.06 MR group versus SEVO group. SEVO group&#x02009;= Induction of anaesthesia with sevoflurane. MR group&#x02009;=&#x02009;Induction of anaesthesia with rocuronium.</p></caption><graphic xlink:href="1471-2253-14-39-3"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Patients (%) with excellent (black bars), good (grey bars) and poor intubation conditions (white bars) for subscore vocal cords.</bold> MR group versus SEVO group: p&#x02009;=&#x02009;0.59. SEVO group&#x02009;= Induction of anaesthesia with sevoflurane. MR group&#x02009;=&#x02009;Induction of anaesthesia with rocuronium.</p></caption><graphic xlink:href="1471-2253-14-39-4"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Patients (%) with excellent (black bars), good (grey bars) and poor intubation conditions (white bars) for subscore reaction to tube insertion or cuff inflation.</bold> *p&#x02009;=&#x02009;0.02 MR group versus SEVO group. SEVO group&#x02009;=&#x02009;Induction of anaesthesia with sevoflurane. MR group&#x02009;=&#x02009;Induction of anaesthesia with rocuronium.</p></caption><graphic xlink:href="1471-2253-14-39-5"/></fig><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Intubating variables and conditions during tracheal extubation</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th rowspan="2" align="left" valign="top">&#x000a0;</th><th align="left" valign="bottom"><bold>SEVO group</bold><hr/></th><th align="left" valign="bottom"><bold>MR group</bold><hr/></th><th rowspan="2" align="left" valign="top"><bold>P</bold></th></tr><tr><th align="left"><bold>(n&#x02009;=&#x02009;39)</bold></th><th align="left"><bold>(n&#x02009;=&#x02009;40)</bold></th></tr></thead><tbody><tr><td align="left" valign="bottom">Intubating variables<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Mallampati I/II/III<hr/></td><td align="left" valign="bottom">20/19/0<hr/></td><td align="left" valign="bottom">18/21/1<hr/></td><td align="left" valign="bottom">0.55<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Cormack grades 1/2<hr/></td><td align="left" valign="bottom">26/13<hr/></td><td align="left" valign="bottom">24/16<hr/></td><td align="left" valign="bottom">0.70<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Application of BURP<hr/></td><td align="left" valign="bottom">8<hr/></td><td align="left" valign="bottom">12<hr/></td><td align="left" valign="bottom">0.48<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Time for intubation (s)<hr/></td><td align="left" valign="bottom">21&#x02009;&#x000b1;&#x02009;17<hr/></td><td align="left" valign="bottom">19&#x02009;&#x000b1;&#x02009;12<hr/></td><td align="left" valign="bottom">0.44<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Attempts (n) 1/2<hr/></td><td align="left" valign="bottom">36/3<hr/></td><td align="left" valign="bottom">35/5<hr/></td><td align="left" valign="bottom">0.71<hr/></td></tr><tr><td align="left" valign="bottom">Extubating conditions<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left">&#x02003;&#x02002;Coughing and movement of limbs excellent/good/poor</td><td align="left">1/21/17</td><td align="left">3/26/11</td><td align="left">0.25</td></tr></tbody></table><table-wrap-foot><p>Values are mean&#x02009;&#x000b1;&#x02009;SD or numbers. BURP&#x02009;=&#x02009;back upward right pressure.</p><p>SEVO group&#x02009;=&#x02009;Induction of anaesthesia with sevoflurane.</p><p>MR group&#x02009;=&#x02009;Induction of anaesthesia with rocuronium.</p></table-wrap-foot></table-wrap></sec><sec><title>Hoarseness and sore throat</title><p>The overall incidence of hoarseness was 21.5%, with no significant difference between the groups. The overall incidence of sore throat was 52%, again with no significant difference between groups. No patient suffered from hoarseness or sore throat exceeding 72&#x000a0;hours.</p></sec><sec><title>Vocal cord injuries</title><p>The overall incidence of vocal cord injuries was 12.5% (Table&#x000a0;<xref ref-type="table" rid="T5">5</xref>). There were two haematomas and six cases of oedema, but no granulomas. Slight changes, such as erythema, were found in 13 patients in the SEVO group and eight in the MR group (n.s.).</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Vocal cord injuries and erythema</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th rowspan="2" align="left" valign="top">&#x000a0;</th><th align="left" valign="bottom"><bold>SEVO group</bold><hr/></th><th align="left" valign="bottom"><bold>MR group</bold><hr/></th><th rowspan="2" align="left" valign="top"><bold>P</bold></th></tr><tr><th align="left"><bold>(n&#x02009;=&#x02009;31)</bold></th><th align="left"><bold>(n&#x02009;=&#x02009;33)</bold></th></tr></thead><tbody><tr><td align="left" valign="bottom">Incidence of injuries<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Haematoma, oedema<hr/></td><td align="left" valign="bottom">4 (13)<hr/></td><td align="left" valign="bottom">4 (12)<hr/></td><td align="left" valign="bottom">1.00<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Granuloma<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">-<hr/></td></tr><tr><td align="left" valign="bottom">Slight changes<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Erythema<hr/></td><td align="left" valign="bottom">13 (42)<hr/></td><td align="left" valign="bottom">8 (24)<hr/></td><td align="left" valign="bottom">0.21<hr/></td></tr><tr><td align="left" valign="bottom">Side (erythema and injuries)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Bilateral<hr/></td><td align="left" valign="bottom">16<hr/></td><td align="left" valign="bottom">11<hr/></td><td align="left" valign="bottom">0.22<hr/></td></tr><tr><td align="left" valign="bottom">&#x02003;&#x02002;Left<hr/></td><td align="left" valign="bottom">0<hr/></td><td align="left" valign="bottom">1 (erythema)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left">&#x02003;&#x02002;Right</td><td align="left">1 (hematoma)</td><td align="left">0</td><td align="left">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p>Values are numbers (%).</p><p>SEVO group&#x02009;=&#x02009;Induction of anaesthesia with sevoflurane.</p><p>MR group&#x02009;=&#x02009;Induction of anaesthesia with rocuronium.</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Tracheal intubation with propofol 1.5&#x000a0;mg&#x000b7;kg<sup>-1</sup>, remifentanil 0.30&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup>&#x000b7;min<sup>-1</sup> and sevoflurane 1.0 MAC was feasible and safe, but intubating conditions were not as good as in the rocuronium group. Acceptable intubating conditions were present in 82% of the patients in the SEVO group, and the subscore for the vocal cords was acceptable in 98%. MAP and ephedrine application were similar in the two groups, as were vocal cord injuries.</p><p>Tracheal intubation without NMBAs is performed more frequently, especially in ambulatory surgery [<xref ref-type="bibr" rid="B14">14</xref>]. In Germany in 2005, 20% of elective tracheal intubations were performed without NMBAs [<xref ref-type="bibr" rid="B15">15</xref>]. The laryngeal mask offers an alternative, but for surgery in the prone position, laparoscopic or ENT surgery, tracheal intubation is essential [<xref ref-type="bibr" rid="B16">16</xref>]. Intubation without NMBAs avoids postoperative residual blockade and allergic reactions to muscle relaxants.</p><p>Combining propofol with remifentanil, 1.0 to 4.0&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup> provided acceptable intubating conditions [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. Remifentanil 2&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup> and propofol 2.0&#x000a0;mg&#x000b7;kg<sup>-1</sup> were sufficient to obtain excellent intubating conditions in 11 of 12 healthy volunteers [<xref ref-type="bibr" rid="B17">17</xref>]. The drugs were given over 5 to 10&#x000a0;seconds, the propofol immediately after the remifentanil, a method which is safe in healthy volunteers or young patients, but not for patients of ASA grade II or III. As much as 4.0&#x000a0;&#x003bc;g&#x000b7;kg<sup>1</sup> may be necessary to obtain excellent intubating conditions [<xref ref-type="bibr" rid="B18">18</xref>]. Remifentanil&#x02009;&#x02265; 2&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup> is not suitable for old patients or those with cardiovascular disease because it is associated with arterial hypotension and bradycardia [<xref ref-type="bibr" rid="B18">18</xref>]. In one observational study the choice of agent depended on the decision of the anesthesiologist [<xref ref-type="bibr" rid="B5">5</xref>]. Acceptable intubating conditions were found in 98.2% of the patients in the relaxant-free intubating group; post-intubation laryngeal symptoms like sore throat and dysphonia were comparable between groups. In the relaxant-free group the median dosage of propofol was 3.64&#x000a0;mg&#x000b7;kg<sup>-1</sup>, supplemented with sufentanil [<xref ref-type="bibr" rid="B5">5</xref>]. Arterial hypotension was observed in 14% of patients, to a similar degree in the two groups. Patients in the relaxant-free group, however, were significantly younger and in better ASA grades [<xref ref-type="bibr" rid="B5">5</xref>]. Others found that when NMBAs are omitted, difficult intubation is more common [<xref ref-type="bibr" rid="B19">19</xref>].</p><p>Significantly fewer patients in our SEVO group had acceptable intubating conditions. The subscore vocal cords, however, was acceptable in all SEVO patients except one. Sevoflurane relaxes the bronchial muscles and possibly also the laryngeal muscles [<xref ref-type="bibr" rid="B20">20</xref>]. The other subscores, however, were significantly worse in the SEVO group.</p><p>Sevoflurane has been used as the sole agent for tracheal intubation; the ED<sub>95</sub> for tracheal intubation was 8.07% (end-tidal concentration) [<xref ref-type="bibr" rid="B21">21</xref>]. Conditions after induction with sevoflurane 6% and N<sub>2</sub>O 66% in O<sub>2</sub> were comparable to those with succinylcholine 1.5&#x000a0;mg&#x000b7;kg<sup>-1</sup>[<xref ref-type="bibr" rid="B22">22</xref>]. This technique has been proposed for patients in whom succinylcholine is contraindicated [<xref ref-type="bibr" rid="B22">22</xref>]. Mean arterial pressure and heart rate were significantly lower immediately before tracheal intubation with sevoflurane. Adding remifentanil 2.0&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup> to sevoflurane 8 Vol% resulted in acceptable intubating conditions in 29 of 30 patients [<xref ref-type="bibr" rid="B7">7</xref>], a similar incidence to intubating conditions with rocuronium 0.6&#x000a0;mg&#x000b7;kg<sup>-1</sup>[<xref ref-type="bibr" rid="B23">23</xref>]. Cros et al. applied a modified Dixon&#x02019;s up-and-down method to remifentanil 1.0&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup> followed by an infusion of 0.25&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup>&#x000b7;min<sup>-1</sup>, increasing or decreasing sevoflurane in 0.5% steps. The concentration of sevoflurane for acceptable intubating conditions was 2.5&#x02009;&#x000b1;&#x02009;0.7% [<xref ref-type="bibr" rid="B24">24</xref>]. Sevoflurane 8 Vol% combined with remifentanil 2.0&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup> caused a significant reduction of mean arterial pressure in young ambulatory patients (median age 16 and 18&#x000a0;years) [<xref ref-type="bibr" rid="B7">7</xref>]. In our study, MAP decreased in both groups by about 30%, and ephedrine use was similar. MAP decreased more than expected in our patients (mean ages 48 and 50&#x000a0;years), who were much older than those of Cagiran et al. [<xref ref-type="bibr" rid="B7">7</xref>].</p><p>Our study included patients of ASA III grade with coronary artery and cerebrovascular disease. The heart rate was significantly lower after tracheal intubation with sevoflurane, which is advantageous for patients with coronary heart disease.</p><p>Avoiding neuromuscular blockade may increase the risk of difficult mask ventilation [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. In a Danish observational study, tracheal intubation was difficult in 5.1% of 103,812 patients; avoiding neuromuscular blockade was one risk factor in the multivariate analysis (odds ratio 1.48) [<xref ref-type="bibr" rid="B25">25</xref>]. Neuromuscular blockade with rocuronium facilitated mask ventilation significantly compared with saline; in all 42 patients with rocuronium, ventilation was possible by mask [<xref ref-type="bibr" rid="B26">26</xref>]. In an observational study of 53041 patients in whom mask ventilation was attempted, it was impossible in 77 (0.15%); 73 patients had received a neuromuscular blocking drug during management of the airway and neuromuscular blockade did not improve matters [<xref ref-type="bibr" rid="B27">27</xref>]. Changes caused by radiotherapy of the neck were the most important risk factor for impossible mask ventilation [<xref ref-type="bibr" rid="B27">27</xref>]. Difficult mask ventilation combined with difficult laryngoscopy was observed in 698 patients (0.40%) from 176,679 patients [<xref ref-type="bibr" rid="B28">28</xref>]. Independent risk factors for difficult mask ventilation combined with difficult laryngoscopy included radiotherapy changes, the presence of teeth, Mallampati III or IV and male sex. The impact of neuromuscular blocking agents could not be assessed [<xref ref-type="bibr" rid="B28">28</xref>].</p><p>Tracheal intubation with propofol and fentanyl alone was associated with a greater frequency and severity of hoarseness and vocal cord injuries compared with a group receiving these drugs and atracurium; intubating conditions were better with atracurium [<xref ref-type="bibr" rid="B3">3</xref>]. Without rocuronium, there was more hoarseness and intubating conditions were worse [<xref ref-type="bibr" rid="B17">17</xref>]. Nevertheless, Bouvet et al. showed that propofol and remifentanil were associated with a similar incidence of hoarseness and vocal cord injuries to cisatracurium [<xref ref-type="bibr" rid="B29">29</xref>], although fibroscopic examination was done 48&#x000a0;hours after surgery only in patients with persisted hoarseness; moreover, small tubes with an ID of 6.5 or 7.0&#x000a0;mm were used [<xref ref-type="bibr" rid="B29">29</xref>]. The incidence of vocal cord injuries in patients receiving NMBAs was up to 27%, and 42% in patients receiving propofol and fentanyl without NMBAs [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B30">30</xref>-<xref ref-type="bibr" rid="B33">33</xref>]. In the present study, however, we used remifentanil instead of fentanyl, and also sevoflurane. Vocal cord injuries such as haematoma and oedema were present in our study in 12.5%; the incidence of erythema was comparable between groups. We suppose that sevoflurane contributed to this low incidence of vocal cord injuries because the intubating conditions at the vocal cords were clinically acceptable in 98%. Obregon et al. showed that adding sevoflurane to propofol and remifentanil gave the same incidence of hoarseness as propofol, remifentanil and rocuronium [<xref ref-type="bibr" rid="B34">34</xref>]. We confirmed these results; in addition, we showed that laryngeal injuries were not more common under sevoflurane anaesthesia. Vocal cord injuries may occur during tracheal intubation, during surgery and at the end of anaesthesia, when the tube is removed. Therefore, we assessed not only intubating conditions, but also extubating conditions to reveal possible risk factors for vocal cord injuries. The duration of anaesthesia was significantly greater in the MR group, which was unexpected as the patients were randomised. Duration of anaesthesia exceeding five hours is a risk factor for hoarseness or sore throat [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]; our anaesthetics lasted less than four hours. The head was not moved during ear surgery; therefore, we suppose that duration of anaesthesia had no additional effect on laryngeal morbidity.</p><p>Our study has two more limitations. Firstly, it did not include any patients with the criteria of difficult intubation because we wanted to have comparable patients in both groups. Second, the investigator who assessed conditions at intubation could not be blinded as to the presence of sevoflurane. However, the investigator who studied hoarseness and sore throat up to 72&#x000a0;hours was blinded as was the ENT physician who performed the videolaryngoscopy.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In conclusion, we showed that intubating conditions with propofol 1.5&#x000a0;mg&#x000b7;kg<sup>-1</sup>, remifentanil 0.30&#x000a0;&#x003bc;g&#x000b7;kg<sup>-1</sup>&#x000b7;min<sup>-1</sup> and sevoflurane 1.0 MAC-instead of rocuronium 0.45&#x000a0;mg&#x000b7;kg<sup>-1</sup>-were acceptable in 82% of patients although conditions were better with rocuronium. The absence of a neuromuscular blocking agent did not affect the incidence and severity of vocal cord injuries.</p></sec><sec><title>Appendix</title><sec><title>Hoarseness, sore throat and vocal cord pathologies</title><p>A. Hoarseness [<xref ref-type="bibr" rid="B3">3</xref>]</p><p>Do you have any hoarseness?</p><p>No&#x02009;=&#x02009;0; yes was graded as follows:</p><p>1&#x02009;=&#x02009;noticed by patient, 2&#x02009;=&#x02009;obvious to observer, 3&#x02009;=&#x02009;aphonia.</p><p>B. Sore throat [<xref ref-type="bibr" rid="B13">13</xref>]</p><p>Do you have any sore throat?</p><p>No&#x02009;=&#x02009;0; if yes, sore throat was graded as follows: 1&#x02009;=&#x02009;mild (pain with deglutition), 2&#x02009;=&#x02009;moderate (pain present constantly and increasing with deglutition), 3&#x02009;=&#x02009;severe (pain interfering with eating and requiring analgesic medication).</p><p>C. Vocal cord pathologies [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B33">33</xref>]</p><p>Location: unilateral (left or right vocal cord) or bilateral (both vocal cords).</p><p>Morphology:</p><p>&#x02013; Slight changes: erythema&#x02009;=&#x02009;redness of the mucosa.</p><p>&#x02013; Vocal cord injuries: oedema&#x02009;=&#x02009;swollen mucosa at the vocal folds, haematoma&#x02009;=&#x02009;bleeding into vocal cord, granuloma&#x02009;=&#x02009;granulation tissue remains as chronic, localised, rounded tissue.</p><p>D. Intubating variables</p><p>&#x02013; Time for intubation&#x02009;=&#x02009;time in seconds from the initial inserting of the laryngoscope into the patient&#x02019;s mouth until inflation of the cuff.</p><p>&#x02013; Number of intubating attempts.</p></sec></sec><sec><title>Competing interests</title><p>There was no financial support or sponsorship. None of the authors has any conflict of interest.</p></sec><sec><title>Authors&#x02019; contribution</title><p>TM made substantial contributions to conception and design, acquisition of data, and statistical analysis and interpretation of data; he drafted the article and he approved the final version to be published. RMJ made substantial contributions to conception and design; she performed the tracheal intubations; she revised the article critically for important intellectual content; and she approved the final version of the manuscript. SM made substantial contributions to the conception and to the design and acquisition of data; she revised the manuscript before submission and approved the final version. CH made substantial contributions to design and acquisition of data; she performed the videolaryngoscopy, revised the article critically for important intellectual content, and approved the final version of the manuscript. AK made substantial contributions to acquisition of data and interpretation of data; she performed the videolaryngoscopy and revised the article before submitting. MS made substantial contributions to conception and design, acquisition of data, and interpretation of data, revised the article critically for important intellectual content, and approved the final version. HWP made substantial contributions to conception and design and analysis of data; he revised the article and approved the final version. GNS made substantial contributions to conception and design and interpretation of data, revised the manuscript and approved the final version. AV made substantial contributions to conception and design, collected and analysed data, performed the videolaryngoscopy, revised the manuscript for important intellectual content, and approved the final version of the manuscript before submitting it. All authors read and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2253/14/39/prepub">http://www.biomedcentral.com/1471-2253/14/39/prepub</ext-link></p></sec></body><back><sec><title>Acknowledgements</title><p>No persons other than the authors listed made substantial contributions to conception, design, acquisition of data, analysis and interpretation of data and preparation of the manuscript. There was no funding for any of the authors and there was no funding for the manuscript preparation.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Bouvet</surname><given-names>L</given-names></name><name><surname>Stoian</surname><given-names>A</given-names></name><name><surname>Rimmel&#x000e9;</surname><given-names>T</given-names></name><name><surname>Allaouchiche</surname><given-names>B</given-names></name><name><surname>Chassard</surname><given-names>D</given-names></name><name><surname>Boselli</surname><given-names>E</given-names></name><article-title>Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol</article-title><source>Anaesthesia</source><year>2009</year><volume>64</volume><fpage>719</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2044.2009.05916.x</pub-id><pub-id pub-id-type="pmid">19624626</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Stevens</surname><given-names>JB</given-names></name><name><surname>Wheatley</surname><given-names>L</given-names></name><article-title>Tracheal intubation in ambulatory surgery patients: using remifentanil and propofol without muscle relaxants</article-title><source>Anesth Analg</source><year>1998</year><volume>86</volume><fpage>45</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">9428849</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Mencke</surname><given-names>T</given-names></name><name><surname>Echternach</surname><given-names>M</given-names></name><name><surname>Kleinschmidt</surname><given-names>S</given-names></name><name><surname>Lux</surname><given-names>P</given-names></name><name><surname>Barth</surname><given-names>V</given-names></name><name><surname>Plinkert</surname><given-names>PK</given-names></name><name><surname>Fuchs-Buder</surname><given-names>T</given-names></name><article-title>Laryngeal morbidity and quality of tracheal intubation. A randomized controlled trial</article-title><source>Anesthesiology</source><year>2003</year><volume>98</volume><fpage>1049</fpage><lpage>1056</lpage><pub-id pub-id-type="doi">10.1097/00000542-200305000-00005</pub-id><pub-id pub-id-type="pmid">12717124</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Erhan</surname><given-names>E</given-names></name><name><surname>Ugur</surname><given-names>G</given-names></name><name><surname>Alper</surname><given-names>I</given-names></name><name><surname>Gunusen</surname><given-names>I</given-names></name><name><surname>Ozyar</surname><given-names>B</given-names></name><article-title>Tracheal intubation without muscle relaxants: remifentanil or alfentanil in combination with propofol</article-title><source>Eur J Anaesthesiol</source><year>2003</year><volume>20</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1097/00003643-200301000-00007</pub-id><pub-id pub-id-type="pmid">12557834</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Baillard</surname><given-names>C</given-names></name><name><surname>Adnet</surname><given-names>F</given-names></name><name><surname>Borron</surname><given-names>SW</given-names></name><name><surname>Racine</surname><given-names>SX</given-names></name><name><surname>Ait Kaci</surname><given-names>F</given-names></name><name><surname>Fournier</surname><given-names>JL</given-names></name><name><surname>Larmignat</surname><given-names>P</given-names></name><name><surname>Cupa</surname><given-names>M</given-names></name><name><surname>Samama</surname><given-names>CM</given-names></name><article-title>Tracheal intubation in routine practice with and without muscular relaxation: an observational study</article-title><source>Eur J Anaesthesiol</source><year>2005</year><volume>22</volume><fpage>672</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1017/S0265021505001110</pub-id><pub-id pub-id-type="pmid">16163913</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Erhan</surname><given-names>E</given-names></name><name><surname>Ugur</surname><given-names>G</given-names></name><name><surname>Gunusen</surname><given-names>I</given-names></name><name><surname>Alper</surname><given-names>I</given-names></name><name><surname>Ozyar</surname><given-names>B</given-names></name><article-title>Propofol - not thiopental or etomidate - with remifentanil provides adequate intubating conditions in the absence of neuromuscular blockade</article-title><source>Can J Anaesth</source><year>2003</year><volume>50</volume><fpage>108</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1007/BF03017840</pub-id><pub-id pub-id-type="pmid">12560298</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Cagiran</surname><given-names>E</given-names></name><name><surname>Eyigor</surname><given-names>C</given-names></name><name><surname>Balcioglu</surname><given-names>T</given-names></name><name><surname>Uyar</surname><given-names>M</given-names></name><article-title>Tracheal intubation in intellectually disabled patients: clinical usefulness of remifentanil and sevoflurane without a muscle relaxant</article-title><source>J Int Med Res</source><year>2013</year><volume>41</volume><fpage>1632</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1177/0300060513497561</pub-id><pub-id pub-id-type="pmid">24008568</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Goo</surname><given-names>EK</given-names></name><name><surname>Oh</surname><given-names>AY</given-names></name><name><surname>Cho</surname><given-names>SJ</given-names></name><name><surname>Seo</surname><given-names>KS</given-names></name><name><surname>Jeon</surname><given-names>YT</given-names></name><article-title>Optimal remifentanil dosage for intubation without muscle relaxants in elderly patients</article-title><source>Drugs Aging</source><year>2012</year><volume>29</volume><fpage>905</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1007/s40266-012-0019-y</pub-id><pub-id pub-id-type="pmid">23090780</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Schneider</surname><given-names>G</given-names></name><name><surname>Elidrissi</surname><given-names>C</given-names></name><name><surname>Sebel</surname><given-names>PS</given-names></name><article-title>Bispectral index-guided administration of anaesthesia: comparison between remifentanil/propofol and remifentanil/isoflurane</article-title><source>Eur J Anaesthesiol</source><year>2003</year><volume>20</volume><fpage>624</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1097/00003643-200308000-00006</pub-id><pub-id pub-id-type="pmid">12932063</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Fuchs-Buder</surname><given-names>T</given-names></name><name><surname>Claudius</surname><given-names>C</given-names></name><name><surname>Skovgaard</surname><given-names>LT</given-names></name><name><surname>Eriksson</surname><given-names>LI</given-names></name><name><surname>Mirakhur</surname><given-names>RK</given-names></name><name><surname>Viby-Mogensen</surname><given-names>J</given-names></name><article-title>8th International Neuromuscular Meeting: Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision</article-title><source>Acta Anaesthesiol Scand</source><year>2007</year><volume>51</volume><fpage>789</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.2007.01352.x</pub-id><pub-id pub-id-type="pmid">17635389</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="other"><name><surname>Urbaniak</surname><given-names>GC</given-names></name><name><surname>Plous</surname><given-names>S</given-names></name><source>Research Randomizer</source><year>2012</year><comment>URL: <ext-link ext-link-type="uri" xlink:href="http://www.randomizer.org">http://www.randomizer.org</ext-link></comment></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Woo</surname><given-names>P</given-names></name><name><surname>Colton</surname><given-names>R</given-names></name><name><surname>Casper</surname><given-names>J</given-names></name><name><surname>Brewer</surname><given-names>D</given-names></name><article-title>Diagnostic value of stroboscopic examination in hoarse patients</article-title><source>J Voice</source><year>1991</year><volume>5</volume><fpage>231</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/S0892-1997(05)80191-2</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>McHardy</surname><given-names>FE</given-names></name><name><surname>Chung</surname><given-names>F</given-names></name><article-title>Postoperative sore throat: cause, prevention and treatment</article-title><source>Anaesthesia</source><year>1999</year><volume>54</volume><fpage>444</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2044.1999.00780.x</pub-id><pub-id pub-id-type="pmid">10995141</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Eikaas</surname><given-names>H</given-names></name><name><surname>Raeder</surname><given-names>J</given-names></name><article-title>Total intravenous anaesthesia techniques for ambulatory surgery</article-title><source>Curr Opin Anaesthesiol</source><year>2009</year><volume>22</volume><fpage>725</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1097/ACO.0b013e3283310f6b</pub-id><pub-id pub-id-type="pmid">19680121</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Fink</surname><given-names>H</given-names></name><name><surname>Geldner</surname><given-names>G</given-names></name><name><surname>Fuchs-Buder</surname><given-names>T</given-names></name><name><surname>Hofmockel</surname><given-names>R</given-names></name><name><surname>Ulm</surname><given-names>K</given-names></name><name><surname>Wallek</surname><given-names>B</given-names></name><name><surname>Blobner</surname><given-names>M</given-names></name><article-title>Muscle relaxants in Germany 2005: a comparison of application customs in hospitals and private practices</article-title><source>Anaesthesist</source><year>2006</year><volume>55</volume><fpage>668</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1007/s00101-006-1015-6</pub-id><pub-id pub-id-type="pmid">16609885</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Mencke</surname><given-names>T</given-names></name><name><surname>Noeldge-Schomburg</surname><given-names>G</given-names></name><article-title>Laryngeal morbidity after use of the laryngeal mask airway</article-title><source>Acta Anaesthesiol Scand</source><year>2010</year><volume>54</volume><fpage>127</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.2009.02159.x</pub-id><pub-id pub-id-type="pmid">20078448</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Stefanutto</surname><given-names>TB</given-names></name><name><surname>Feiner</surname><given-names>J</given-names></name><name><surname>Krombach</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>R</given-names></name><name><surname>Caldwell</surname><given-names>JE</given-names></name><article-title>Hemoglobin desaturation after propofol/remifentanil-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers</article-title><source>Anesth Analg</source><year>2012</year><volume>114</volume><fpage>980</fpage><lpage>986</lpage><pub-id pub-id-type="doi">10.1213/ANE.0b013e31824e5bc4</pub-id><pub-id pub-id-type="pmid">22492188</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Woods</surname><given-names>AW</given-names></name><name><surname>Allam</surname><given-names>S</given-names></name><article-title>Tracheal intubation without the use of neuromuscular blocking agents</article-title><source>Br J Anaesth</source><year>2005</year><volume>94</volume><fpage>150</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1093/bja/aei006</pub-id><pub-id pub-id-type="pmid">15516354</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Combes</surname><given-names>X</given-names></name><name><surname>Andriamifidy</surname><given-names>L</given-names></name><name><surname>Dufresne</surname><given-names>E</given-names></name><name><surname>Suen</surname><given-names>P</given-names></name><name><surname>Sauvat</surname><given-names>S</given-names></name><name><surname>Scherrer</surname><given-names>E</given-names></name><name><surname>Feiss</surname><given-names>P</given-names></name><name><surname>Marty</surname><given-names>J</given-names></name><name><surname>Duvaldestin</surname><given-names>P</given-names></name><article-title>Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort</article-title><source>Br J Anaesth</source><year>2007</year><volume>99</volume><fpage>276</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1093/bja/aem147</pub-id><pub-id pub-id-type="pmid">17573390</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>SS</given-names></name><name><surname>Goa</surname><given-names>KL</given-names></name><article-title>Sevoflurane: a review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia</article-title><source>Drugs</source><year>1996</year><volume>51</volume><fpage>658</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.2165/00003495-199651040-00009</pub-id><pub-id pub-id-type="pmid">8706599</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Asakura</surname><given-names>N</given-names></name><name><surname>Inomata</surname><given-names>S</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Taguchi</surname><given-names>M</given-names></name><article-title>Determination of end-tidal sevoflurane concentration for tracheal intubation and minimum alveolar anesthetic concentration in adults</article-title><source>Anesth Analg</source><year>1994</year><volume>79</volume><fpage>378</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">7639383</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Iamaroon</surname><given-names>A</given-names></name><name><surname>Pitimana-aree</surname><given-names>S</given-names></name><name><surname>Prechawai</surname><given-names>C</given-names></name><name><surname>Anusit</surname><given-names>J</given-names></name><name><surname>Somcharoen</surname><given-names>K</given-names></name><name><surname>Chaiyaroj</surname><given-names>O</given-names></name><article-title>Endotracheal intubation with thiopental/succinylcholine or sevoflurane-nitrous oxide anesthesia in adults: a comparative study</article-title><source>Anesth Analg</source><year>2001</year><volume>92</volume><fpage>523</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1213/00000539-200102000-00045</pub-id><pub-id pub-id-type="pmid">11159262</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Sparr</surname><given-names>HJ</given-names></name><name><surname>Giesinger</surname><given-names>S</given-names></name><name><surname>Ulmer</surname><given-names>H</given-names></name><name><surname>Hollenstein-Zacke</surname><given-names>M</given-names></name><name><surname>Luger</surname><given-names>TJ</given-names></name><article-title>Influence of induction technique on intubating conditions after rocuronium in adults: comparison with rapid-sequence induction using thiopentone and suxamethonium</article-title><source>Br J Anaesth</source><year>1996</year><volume>77</volume><fpage>339</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1093/bja/77.3.339</pub-id><pub-id pub-id-type="pmid">8949806</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Cros</surname><given-names>AM</given-names></name><name><surname>Lopez</surname><given-names>C</given-names></name><name><surname>Kandel</surname><given-names>T</given-names></name><name><surname>Sztark</surname><given-names>F</given-names></name><article-title>Determination of sevoflurane alveolar concentration for tracheal intubation with remifentanil, and no muscle relaxant</article-title><source>Anaesthesia</source><year>2000</year><volume>55</volume><fpage>965</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2044.2000.01538.x</pub-id><pub-id pub-id-type="pmid">11012491</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Lundstr&#x000f8;m</surname><given-names>LH</given-names></name><name><surname>M&#x000f8;ller</surname><given-names>AM</given-names></name><name><surname>Rosenstock</surname><given-names>C</given-names></name><name><surname>Astrup</surname><given-names>G</given-names></name><name><surname>G&#x000e4;tke</surname><given-names>MR</given-names></name><name><surname>Wetterslev</surname><given-names>J</given-names></name><article-title>Danish Anaesthesia Database: Avoidance of neuromuscular blocking agents may increase the risk of difficult tracheal intubation: a cohort study of 103,812 consecutive adult patients recorded in the Danish Anaesthesia Database</article-title><source>Br J Anaesth</source><year>2009</year><volume>103</volume><fpage>283</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1093/bja/aep124</pub-id><pub-id pub-id-type="pmid">19457894</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Warters</surname><given-names>RD</given-names></name><name><surname>Szabo</surname><given-names>TA</given-names></name><name><surname>Spinale</surname><given-names>FG</given-names></name><name><surname>DeSantis</surname><given-names>SM</given-names></name><name><surname>Reves</surname><given-names>JG</given-names></name><article-title>The effect of neuromuscular blockade on mask ventilation</article-title><source>Anaesthesia</source><year>2011</year><volume>66</volume><fpage>163</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2044.2010.06601.x</pub-id><pub-id pub-id-type="pmid">21265818</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Kheterpal</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>L</given-names></name><name><surname>Shanks</surname><given-names>AM</given-names></name><name><surname>Tremper</surname><given-names>KK</given-names></name><article-title>Prediction and outcomes of impossible mask ventilation: a review of 50,000 anesthetics</article-title><source>Anesthesiology</source><year>2009</year><volume>110</volume><fpage>891</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e31819b5b87</pub-id><pub-id pub-id-type="pmid">19293691</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Kheterpal</surname><given-names>S</given-names></name><name><surname>Healy</surname><given-names>D</given-names></name><name><surname>Aziz</surname><given-names>MF</given-names></name><name><surname>Shanks</surname><given-names>AM</given-names></name><name><surname>Freundlich</surname><given-names>RE</given-names></name><name><surname>Linton</surname><given-names>F</given-names></name><name><surname>Martin</surname><given-names>LD</given-names></name><name><surname>Linton</surname><given-names>J</given-names></name><name><surname>Epps</surname><given-names>JL</given-names></name><name><surname>Fernandez-Bustamante</surname><given-names>A</given-names></name><name><surname>Jameson</surname><given-names>LC</given-names></name><name><surname>Tremper</surname><given-names>T</given-names></name><name><surname>Tremper</surname><given-names>KK</given-names></name><article-title>Multicenter Perioperative Outcomes Group (MPOG) Perioperative Clinical Research Committee: incidence, predictors, and outcome of difficult mask ventilation combined with difficult laryngoscopy: a report from the multicenter perioperative outcomes group</article-title><source>Anesthesiology</source><year>2013</year><volume>119</volume><fpage>1360</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1097/ALN.0000435832.39353.20</pub-id><pub-id pub-id-type="pmid">24071617</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Bouvet</surname><given-names>L</given-names></name><name><surname>Stoian</surname><given-names>A</given-names></name><name><surname>Jacquot-Laperri&#x000e8;re</surname><given-names>S</given-names></name><name><surname>Allaouchiche</surname><given-names>B</given-names></name><name><surname>Chassard</surname><given-names>D</given-names></name><name><surname>Boselli</surname><given-names>E</given-names></name><article-title>Laryngeal injuries and intubating conditions with or without muscular relaxation: an equivalence study</article-title><source>Can J Anesth</source><year>2008</year><volume>55</volume><fpage>674</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1007/BF03017743</pub-id><pub-id pub-id-type="pmid">18835965</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="book"><name><surname>Benjamin</surname><given-names>B</given-names></name><person-group person-group-type="editor">Cummings CW, Frederickson JM</person-group><article-title>Laryngeal trauma from intubation: endoscopic evaluation and classification</article-title><source>Otolaryngology &#x00026; Head &#x00026; Neck Surgery</source><year>2001</year><publisher-name>St. Louis: Mosby</publisher-name><fpage>2013</fpage><lpage>2035</lpage></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Peppard</surname><given-names>SB</given-names></name><name><surname>Dickens</surname><given-names>JH</given-names></name><article-title>Laryngeal injury following short-term intubation</article-title><source>Ann Otol Rhinol Laryngol</source><year>1983</year><volume>92</volume><fpage>327</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">6881831</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Kambic</surname><given-names>V</given-names></name><name><surname>Radsel</surname><given-names>Z</given-names></name><article-title>Intubation lesions of the larynx</article-title><source>Br J Anaesth</source><year>1978</year><volume>50</volume><fpage>587</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1093/bja/50.6.587</pub-id><pub-id pub-id-type="pmid">666934</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Mencke</surname><given-names>T</given-names></name><name><surname>Echternach</surname><given-names>M</given-names></name><name><surname>Plinkert</surname><given-names>PK</given-names></name><name><surname>Johann</surname><given-names>U</given-names></name><name><surname>Afan</surname><given-names>N</given-names></name><name><surname>Rensing</surname><given-names>H</given-names></name><name><surname>Noeldge-Schomburg</surname><given-names>G</given-names></name><name><surname>Knoll</surname><given-names>H</given-names></name><name><surname>Larsen</surname><given-names>R</given-names></name><article-title>Does the timing of tracheal intubation based on neuromuscular monitoring decrease laryngeal injury? A randomized, prospective, controlled trial</article-title><source>Anesth Analg</source><year>2006</year><volume>102</volume><fpage>306</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1213/01.ANE.0000181290.37527.CE</pub-id><pub-id pub-id-type="pmid">16368848</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Gonz&#x000e1;lez Obreg&#x000f3;n</surname><given-names>MP</given-names></name><name><surname>Rivera D&#x000ed;az</surname><given-names>RC</given-names></name><name><surname>Ord&#x000f3;&#x000f1;ez Molina</surname><given-names>JE</given-names></name><name><surname>Rivera Diaz</surname><given-names>JS</given-names></name><name><surname>Velasquez Ossa</surname><given-names>LF</given-names></name><name><surname>Pineda Ibarra</surname><given-names>C</given-names></name><name><surname>Serna Gutierrez</surname><given-names>J</given-names></name><name><surname>Franco Botero</surname><given-names>V</given-names></name><article-title>Tracheal intubation quality under remifentanil-propofol with sevoflurane compared with remifentanil-propofol with rocuronium: a randomized double-blind clinical trial</article-title><source>Rev Esp Anestesiol Reanim</source><year>2010</year><volume>57</volume><fpage>351</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/S0034-9356(10)70247-4</pub-id><pub-id pub-id-type="pmid">20645486</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Mendels</surname><given-names>EJ</given-names></name><name><surname>Brunings</surname><given-names>JW</given-names></name><name><surname>Hamaekers</surname><given-names>AE</given-names></name><name><surname>Stokroos</surname><given-names>RJ</given-names></name><name><surname>Kremer</surname><given-names>B</given-names></name><name><surname>Baijens</surname><given-names>LW</given-names></name><article-title>Adverse laryngeal effects following short-term general anesthesia</article-title><source>Arch Otolaryngol Head Neck Surg</source><year>2012</year><volume>138</volume><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1001/archoto.2011.1427</pub-id><pub-id pub-id-type="pmid">22431870</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Hamdan</surname><given-names>AL</given-names></name><name><surname>Sibai</surname><given-names>A</given-names></name><name><surname>Rameh</surname><given-names>C</given-names></name><name><surname>Kanazeh</surname><given-names>G</given-names></name><article-title>Short-term effects of endotracheal intubation on voice</article-title><source>J Voice</source><year>2007</year><volume>21</volume><fpage>762</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1016/j.jvoice.2006.06.003</pub-id><pub-id pub-id-type="pmid">16905292</pub-id></mixed-citation></ref></ref-list></back></article>